China looks good for growth of Allergan's Botox and medical aesthetics
This article was originally published in Scrip
Executive Summary
Appearance-conscious China has already become the world's third-largest market for plastic surgery, closing the gap on Brazil and the US, and is now an attractive market for companies like medical aesthetics specialist, Allergan, and its portfolio of cosmetically oriented pharmaceuticals including its wrinkle treatment Botox.